Literature DB >> 18060623

Antitumor effect of interferon-alpha on U937 human acute leukemia cells in vitro and its molecular mechanism.

Chun Zhang1, Guohui Cui, Yan Chen, Ke Fan.   

Abstract

In order to investigate the antitumor effect and molecular mechanism of interferon-alpha (IFN-alpha) on human acute myeloid leukemia cell line U937 cells in vitro, the proliferation of U937 cells was determined by MTT assay, the apoptosis rate was analyzed by flow cytometry (FCM), and the mRNA expression of cell cycle regulatory protein cyclin E was detected by RT-PCR. The results showed that IFN-alpha could inhibit the proliferation of U937 cells significantly in a dose-and time-dependent way (P<0.01), and induce the apoptosis of U937 cells also in a dose-and time-dependent manner at the concentration of 1000-4000 U/L (P<0.01). The apoptosis rate of U937 cells was even over 50% when cultured with IFN-alpha for 36-48 h at the concentration of 2000-4000 U/L. Moreover, the expression of cyclin E mRNA was markedly inhibited by the addition of IFN-alpha, and the inhibition was time-dependent (P<0.01). It was concluded that the anti-leukemia mechanism of IFN-alpha might be correlated with its antiproliferative and apoptotic inducing effects, and the down-regulation of the cyclin E expression might be one of its molecular mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060623     DOI: 10.1007/s11596-007-0509-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  IFN-alpha1,8 inhibits tumor-induced angiogenesis in murine angiosarcomas.

Authors:  Kevin L Taylor; Rhonda K Oates; Ron Grane; Douglas W Leaman; Ernest C Borden; Daniel J Lindner
Journal:  J Interferon Cytokine Res       Date:  2006-05       Impact factor: 2.607

2.  Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.

Authors:  A S Lundberg; R A Weinberg
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

3.  Cdc2-cyclin E complexes regulate the G1/S phase transition.

Authors:  Eiman Aleem; Hiroaki Kiyokawa; Philipp Kaldis
Journal:  Nat Cell Biol       Date:  2005-07-10       Impact factor: 28.824

4.  Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma.

Authors:  Daniel G Rosen; Gong Yang; Michael T Deavers; Anais Malpica; John J Kavanagh; Gordon B Mills; Jinsong Liu
Journal:  Cancer       Date:  2006-05-01       Impact factor: 6.860

5.  Interferon-alpha enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells.

Authors:  Christian Liedtke; Nadine Gröger; Michael P Manns; Christian Trautwein
Journal:  J Hepatol       Date:  2005-08-02       Impact factor: 25.083

6.  Sarcoidosis and interferon therapy: report of five cases and review of the literature.

Authors:  Stéphanie Leclerc; Robert P. Myers; Joseph Moussalli; Serge Herson; Thierry Poynard; Olivier Benveniste
Journal:  Eur J Intern Med       Date:  2003-07       Impact factor: 4.487

7.  IFN-alpha and IL-12 activate IFN regulatory factor 1 (IRF-1), IRF-4, and IRF-8 gene expression in human NK and T cells.

Authors:  Anne Lehtonen; Riikka Lund; Riitta Lahesmaa; Ilkka Julkunen; Timo Sareneva; Sampsa Matikainen
Journal:  Cytokine       Date:  2003-11-07       Impact factor: 3.861

8.  Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas.

Authors:  J D Kelly; J Dai; P Eschwege; J S Goldberg; B P Duggan; K E Williamson; N H Bander; D M Nanus
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

  8 in total
  1 in total

1.  TLR4-Mediated Pathway Triggers Interferon-Independent G0 Arrest and Antiviral SAMHD1 Activity in Macrophages.

Authors:  Petra Mlcochova; Helena Winstone; Lorena Zuliani-Alvarez; Ravindra K Gupta
Journal:  Cell Rep       Date:  2020-03-24       Impact factor: 9.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.